Pfizer Inc Analyst Ratings
$25.90
At close: May 22, 5:00 PM EST
$25.90
After Hours: May 22, 7:47 PM EST
Highest Price Target1
$45.00
Lowest Price Target1
$25.00
Consensus Price Target1
$30.86
Pfizer Analyst Ratings and Price Targets | NYSE:PFE | Benzinga
Pfizer Inc has a consensus price target of $30.86 based on the ratings of 29 analysts. The high is $45 issued by Cantor Fitzgerald on October 25, 2024. The low is $25 issued by RBC Capital on April 20, 2026. The 3 most-recent analyst ratings were released by Citigroup, RBC Capital, and CICC on April 29, 2026, April 20, 2026, and April 16, 2026, respectively. With an average price target of $28.33 between Citigroup, RBC Capital, and CICC, there’s an implied 9.39% upside for Pfizer Inc from these most-recent analyst ratings.
Analyst Trends and Forecast
Analyst Rating and Forecast
Analyst Firms Making Recommendations1
Citigroup
RBC Capital
CICC
UBS
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Pfizer
FAQ
Q
What is the target price for Pfizer (PFE) stock?
A
The latest price target for Pfizer (NYSE:PFE) was reported by Citigroup on April 29, 2026. The analyst firm set a price target for $27.00 expecting PFE to rise to within 12 months (a possible 4.25% upside). 25 analyst firms have reported ratings in the last year.
Q
What is the most recent analyst rating for Pfizer (PFE)?
A
The latest analyst rating for Pfizer (NYSE:PFE) was provided by Citigroup, and Pfizer maintained their neutral rating.
Q
When was the last upgrade for Pfizer (PFE)?
A
The last upgrade for Pfizer Inc happened on March 2, 2026 when Argus Research raised their price target to $35. Argus Research previously had a hold for Pfizer Inc.
Q
When was the last downgrade for Pfizer (PFE)?
A
The last downgrade for Pfizer Inc happened on April 8, 2025 when Goldman Sachs changed their price target from $32 to $25 for Pfizer Inc.
Q
When is the next analyst rating going to be posted or updated for Pfizer (PFE)?
A
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on April 29, 2026 so you should expect the next rating to be made available sometime around April 29, 2027.
Q
Is the Analyst Rating Pfizer (PFE) correct?
A
While ratings are subjective and will change, the latest Pfizer (PFE) rating was a maintained with a price target of $26.00 to $27.00. The current price Pfizer (PFE) is trading at is $25.90, which is out of the analyst’s predicted range.
